Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Use of Mesenchymal Stem Cells in the Process of Treatment and Tissue Regeneration After Recovery in Patients With Covid-19 Publisher Pubmed



Saburi E1 ; Abazari MF2 ; Hassannia H3 ; Mansour RN4 ; Eshaghigorji R4 ; Gheibi M4 ; Rahmati M5 ; Enderami SE6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medical Genetics and Molecular Medicine Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Amol Faculty of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran
  4. 4. Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
  5. 5. Department of Medical Biotechnology, Faculty of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran
  6. 6. Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  7. 7. Department of Medical Biotechnology, Faculty of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Source: Gene Published:2021


Abstract

In addition to causing health concerns, the new coronavirus has been considered in the world with its unknown mechanism of physiopathogenesis and long-term effects after patient recovery. Pulmonary, renal, hepatic and cardiac complications have been reported so far. Beside the researchers' focus on finding vaccines and using conventional therapies, cell-based therapy might be an effective therapeutic strategy. The use of mesenchymal stem cells (MSCs) is one of the options due to their immunomodulatory properties and their proven effects in the treatment of many diseases. As MSCs are not infected with covid-19, there is evidence that it modulates the immune system and prevents the virus from clotting. Despite the beginning of numerous clinical trials in the use of mesenchymal stem cells, it is necessary to set a practical guideline that specifies items such as cell origin, number of cells, frequency of injection, injection site, etc. © 2021 Elsevier B.V.
Related Docs
View other Related Docs
1. The Role of Mesenchymal Stromal Cells in Immune Modulation of Covid-19: Focus on Cytokine Storm, Stem Cell Research and Therapy (2020)
2. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
3. Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action, Life Sciences (2020)
4. Stem Cell Therapy Potency in Personalizing Severe Covid-19 Treatment, Stem Cell Reviews and Reports (2021)
5. Auxiliary Role of Mesenchymal Stem Cells As Regenerative Medicine Soldiers to Attenuate Inflammatory Processes of Severe Acute Respiratory Infections Caused by Covid-19, Cell and Tissue Banking (2020)
6. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
7. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
8. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (19)
Babak Arjmand (4)
Other Related Docs
9. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
10. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
11. Mesenchymal Stromal/Stem Cells (Mscs) and Msc-Derived Extracellular Vesicles in Covid-19-Induced Ards: Mechanisms of Action, Research Progress, Challenges, and Opportunities, International Immunopharmacology (2021)
12. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
13. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)
14. The Prophylaxis and Treatment Potential of Supplements for Covid-19, European Journal of Pharmacology (2020)
15. The Critical Role of Mesenchymal Stromal/Stem Cell Therapy in Covid-19 Patients: An Updated Review, Cell Biochemistry and Function (2021)
16. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
17. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
18. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
19. Cell Therapy in Patients With Covid-19 Using Wharton’S Jelly Mesenchymal Stem Cells: A Phase 1 Clinical Trial, Stem Cell Research and Therapy (2021)
20. Mesenchymal Stem Cells Derived From Perinatal Tissues for Treatment of Critically Ill Covid-19-Induced Ards Patients: A Case Series, Stem Cell Research and Therapy (2021)
21. Hypothesis for the Management and Treatment of the Covid-19-Induced Acute Respiratory Distress Syndrome and Lung Injury Using Mesenchymal Stem Cell-Derived Exosomes, Medical Hypotheses (2020)
22. Natural Killer Cells in Covid-19: From Infection, to Vaccination and Therapy, Future Virology (2023)
23. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
24. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
25. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe Covid-19 Patients, Current Stem Cell Research and Therapy (2024)
26. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
27. A Pharmacology-Based Comprehensive Review on Medicinal Plants and Phytoactive Constituents Possibly Effective in the Management of Covid-19, Phytotherapy Research (2021)
28. Structure-Based Study of Immune Receptors As Eligible Binding Targets of Coronavirus Sars-Cov-2 Spike Protein, Journal of Molecular Graphics and Modelling (2021)
29. Precision Medicine in Infectious Disease, Precision Medicine in Clinical Practice (2022)
30. The Coronavirus Disease 2019 and Effect on Liver Function: A Hidden and Vital Interaction Beyond the Respiratory System, Reviews and Research in Medical Microbiology (2022)
31. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)
32. Post-Discharge Thromboembolic Events in Covid-19 Patients: A Review on the Necessity for Prophylaxis, Clinical and Applied Thrombosis/Hemostasis (2023)
33. Post-Exposure Prophylaxis for Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2023)
34. The Quest for a Better Fight: How Can Nanomaterials Address the Current Therapeutic and Diagnostic Obstacles in the Fight Against Covid-19?, Journal of Drug Delivery Science and Technology (2022)
35. A Review on the Mechanisms Involved in the Immunopathogenesis of Sars-Cov-2, Journal of Military Medicine (2020)
36. Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders, Stem Cell Research and Therapy (2021)
37. Human Placenta-Derived Mesenchymal Stem Cells Transplantation in Patients With Acute Respiratory Distress Syndrome (Ards) Caused by Covid-19 (Phase I Clinical Trial): Safety Profile Assessment, Stem Cell Research and Therapy (2022)
38. Review on Oxidative Stress Relation on Covid-19: Biomolecular and Bioanalytical Approach, International Journal of Biological Macromolecules (2021)
39. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
40. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)
41. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
42. Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy, Transfusion and Apheresis Science (2020)
43. Coronavirus Disease 2019 (Covid-19) in Pediatric Patients With Autoimmune Disorders, European Journal of Pediatrics (2023)
44. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
45. The Promising Approach of Mscs Therapy for Covid-19 Treatment, Cell and Tissue Banking (2023)
46. Evaluation of the Relationship Between Serum Bdnf Concentration and Indicators of Oxidative Stress and Inflammation in Covid-19 Patients With Neurological Disorders - a Pilot Study, Neurological Research (2023)
47. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
48. Covid-19 Immunotherapy: Treatment Based on the Immune Cell-Mediated Approaches, International Immunopharmacology (2022)
49. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
50. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)